Cord blood-derived biologics lead to robust axonal regeneration in benzalkonium chloride-injured mouse corneas by modulating the Il-17 pathway and neuropeptide Y.
Ruojing HuangCaiying SuNa ZhangCongying ShiGuangming PuYong DingWei WeiJian-Su ChenPublished in: Molecular medicine (Cambridge, Mass.) (2024)
Cord blood-derived therapeutics are feasible options for overcoming the sustained injuries induced by BAK in the cornea. They also have potential applications in areas where axonal regeneration is required.